Literature DB >> 511358

Penetration of ampicillin into human bronchial secretions.

E Bergogne-Berezin, G Berthelot, H Kafe, C Morel.   

Abstract

Ampicillin concentrations in serum and bronchial secretions after oral administration of bacampicillin were evaluated. Twenty-eight hospitalized patients with acute bronchopulmonary infections received a single dose of 800 mg of bacampicillin. Samples of bronchial secretions were obtained during diagnostic bronchoscopy and blood samples were drawn simultaneously. Significant concentrations of ampicillin were found in bronchial secretions, the peak level, reached after approximately two hours, being 0.27 micrograms/ml on an average. The penetration of ampicillin into the bronchial secretions after the administration of bacampicillin could be correlated with the degree of bronchial inflammation, as illustrated either by macroscopic purulence or protein concentration in the secretions. The results suggest that bacampicillin is a useful drug in acute bronchopulmonary infections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511358     DOI: 10.1007/bf01659772

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN: SOME PHARMACOLOGICAL OBSERVATION.

Authors:  J R MAY; D M DELVES
Journal:  Lancet       Date:  1965-05-01       Impact factor: 79.321

2.  Bacteriology of sputum in chronic bronchitis.

Authors:  J R MAY; D S MAY
Journal:  Tubercle       Date:  1963-03

3.  Penetration of antibiotics into fibrin loci in vivo. I. Comparison of penetration of ampicillin into fibrin clots, abscesses, and "interstitial fluid".

Authors:  M Barza; L Weinstein
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

4.  Bacampicillin: a new orally well-absorbed derivative of ampicillin.

Authors:  N O Bodin; B Ekström; U Forsgren; L P Jalar; L Magni; C H Ramsay; B Sjöberg
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

  4 in total
  4 in total

1.  Comparison of bacampicillin and amoxicillin in acute otitis media with effusion.

Authors:  H K Kim; C D Bluestone; M M Blatter; K S Reisinger; F P Wucher; D D Rohn; P Fall; K Digaudio; L Rebholz
Journal:  Bull N Y Acad Med       Date:  1983-06

2.  Bacampicillin in the treatment of acute sinusitis and bronchopulmonary disease.

Authors:  J P Simelaro; C Henwood; A Desalvo
Journal:  Bull N Y Acad Med       Date:  1983-06

3.  Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.

Authors:  J Majcher-Peszynska; M Loebermann; S Klammt; S Frimmel; R G Mundkowski; T Welte; E C Reisinger; B Drewelow
Journal:  Infection       Date:  2013-08-01       Impact factor: 3.553

Review 4.  Studies on aminopenicillin developments. Proceedings of a symposium. Concluding remarks.

Authors:  T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.